Category

Clinical Trials

Mats Hansen SpagoPix

New results from Spago Nanomedical

January 14, 2022

Interim results from the second …

Klaas Bakker

Oncopeptide study published in the Lancet

January 14, 2022

Data from the phase 3 …

Evelina Vågesjö Photo Jenny Öhman Nordic Life Science

Ilya Pharma to submit an IND for a Phase 1/2a study

January 12, 2022

Ilya Pharma is planning to …

Sigrid announces proof-of-concept results

December 16, 2021

Sigrid Therapeutics has announced that …

AstraZeneca Research and Development

Updated results from AstraZeneca’s ASCEND trial

December 15, 2021

Updated results from the ASCEND …

Nikolai Brun

Affibody and partners announce positive trial results

December 15, 2021

Affibody, ACELYRIN, and Inmagene Biopharmaceuticals, …

Ultimovacs lab

First patient enrolled in Ultimovacs’ DOVACC trial

December 15, 2021

Ultimovacs has announced that the …

Karl Bergman and Francesco Gatto

Elypta enrolls first patient in AUR93A trial

December 14, 2021

Elypta announces the enrollment of …

AstraZeneca’s new COVID-19 drug to be manufactured in Sweden

December 13, 2021

The last manufacturing steps of …

Susan Galbraith

New results from AstraZeneca’s DESTINY trial

December 13, 2021

New results from the DESTINY-Breast03 …

Inficure Bio team

Positive data from Inficure Bio

December 13, 2021

Together with CymaBay Therapeutics Inficure …

Tumorad

Spago’s Tumorad shows good safety in preclinical studies

December 13, 2021

Spago Nanomedical has completed the …

Maarten de Château

Sixera initiates its first clinical trial on SXR1096

December 7, 2021

Enrollment of patients in the …

Immedica Pharma reports positive Phase 3 results

December 7, 2021

Immedica Pharma has announced the …

Michael Uhlin

XNK Therapeutics initiates proof of concept study

December 7, 2021

XNK Therapeutics will perform a …

clinical trial

Immunicum completes Phase Ib portion of ILIAD study

December 3, 2021

Immunicum has announced the completion …

1
2
3
···
39